No hidden fees • No subscription traps • Physician-led
Transparent Medical Weight Loss Pricing in St. George, Utah
One upfront price covers your medication, supplies, and physician-led care GLP-1 care.​
​Most patients pay about $80–$140 per month during their first 12 weeks.
Designed for long-term affordability with real physician support—whether in clinic or via telehealth.
All-Inclusive GLP-1 Weight Loss Program in Utah
When you compare prices, look at the bottom line. Our inclusive treatment program includes everything you need to safely lose weight.
​​
-
Physician Care: Direct oversight by Dr. Joshua Silva, MD at Potere Health MD
-
Ongoing Clinical Management: Medication titration, monitoring, and treatment adjustments
-
Nutrition & Lifestyle Counseling: Evidence-based guidance to support sustainable weight loss
-
Medication & Supplies: Multi-dose vial of semaglutide or tirzepatide when prescribed, and necessary injection supplies
Compunded GLP-1 Weight Loss Program Pricing (Up to 12 Weeks of Care)
Compounded Semaglutide* (GLP-1) Program (Cost-Effective)
Each treatment phase includes physician-supervised care and 10 mg of medication if prescribed.
​
Most patients average about $80 per month during the initial treatment phase.​
​
-
Start (Initial Treatment) – $239
-
Typically lasts up to 12 weeks during starting titration (~$80/month*)
-
-
Progress (Continued Weight Loss) – $219
-
Maintain (Ongoing Treatment) – $199
1st fill –
Getting Started
You Receive:
10 mg of medication
$80 per mo*
$239.99
*Requires 3 mo purchase up front
Following the clinical trial protocol, we increase the dose every weeks for optimal results
Weeks 1-4
0.25mg weekly dose
Weeks 5-8
0.5mg weekly dose
Weeks 9-12
1.0mg weekly dose
Total:
12 weeks – 8mg medication used
Includes >12 weeks of weight loss treatment
2nd fill –
Continuing Treatment
You Receive:
another 10 mg of medication
$219.99
How long will it last this round?
It depends on your weekly dose.
3rd fill & beyond –
Maintaining Results
You Receive:
another 10 mg of medication
$199.99
What is the average monthly cost?
It will depend on your weekly dose.
*Based on standard starting titration.​
Pricing reflects bundled care including physician-supervised medical care, treatment management, ongoing clinical support, and medication when prescribed. Medication is billed separately by the pharmacy and included within the total program price as posted above. Potere Health MD does not manufacture compounded medications.
​
Compounded semaglutide formulations are not FDA-approved, have not been evaluated for safety or efficacy, and are not generic equivalents to commercial products.
​
Pricing for FDA-approved GLP-1medications (Ozempic/Wegovy) is determined by manufacturers, pharmacies, and individual insurance plans.
​
Vial images are for illustrative purposes only.
Compunded GLP-1/GIP Weight Loss Program Pricing (Up to 12 Weeks of Care)
Compounded Tirzepatide* (GLP-1/GIP) Program (Most Popular)
Each treatment phase includes physician-supervised care and 60 mg of medication if prescribed.
​
Most patients average about $1135 per month during the initial treatment phase.
​
-
Start (Initial Treatment) – $399
-
Typically lasts up to 12 weeks during starting titration (~$140/month*)
-
-
Progress (Continued Weight Loss) – $375
-
Maintain (Ongoing Treatment) – $350
1st fill –
Getting Started
You Receive:
60 mg of medication
$135 per mo*
$399.99
*Requires 3 mo purchase up front
Following the clinical trial protocol, we increase the dose every weeks for optimal results
Weeks 1-4
2.5mg weekly dose
Weeks 5-8
5.0mg weekly dose
Weeks 9-12
7.5mg weekly dose
Total:
12 weeks – 60mg medication used
Includes 12 weeks of weight loss treatment
2nd fill –
Continuing Treatment
You Receive:
another 10 mg of medication
$375
How long will it last this round?
It depends on your weekly dose.
3rd fill & beyond –
Maintaining Results
You Receive:
another 10 mg of medication
$350
What is the average monthly cost?
It will depend on your weekly dose.
*Based on standard starting titration.​
Pricing reflects bundled care including physician-supervised medical care, treatment management, ongoing clinical support, and medication when prescribed. Medication is billed separately by the pharmacy and included within the total program price as posted above. Potere Health MD does not manufacture compounded medications.
​
Compounded tirzepatide formulations are not FDA-approved, have not been evaluated for safety or efficacy, and are not generic equivalents to commercial products.
​
Pricing for FDA-approved GLP-1/GIP medications (Mounjaro/Zepbound) is determined by manufacturers, pharmacies, and individual insurance plans.
​
Vial images are for illustrative purposes only.
Understanding GLP-1 Dosing & Treatment Duration
How long a vial of medication lasts depends on your prescribed dose.
The table below shows approximate duration at common dosing levels.
Compounded Tirzepatide (GLP-1/GIP) 60 mg Vial
​
Dose ............ How long it lasts
2.5 mg ............... 24 weeks
5 mg .................. 12 weeks
7.5 mg .................. 8 weeks
10 mg .................... 6 weeks
​
​
Compounded Semaglutide (GIP) 10 mg Vial
Dose ............ How long it lasts
0.25 mg ............. 40 weeks
0.5 mg ............... 20 weeks
1.0 mg ............... 10 weeks
1.7 mg ................ 6 weeks
2.5 mg ................ 4 weeks
​
Dosing and duration vary based on individual treatment plans. Your prescribing physician will determine appropriate dosing and titration.​​​​​​​
Why Our GLP-1 Pricing Decreases Over Time
Real-world data shows many patients stop GLP-1 therapy within the first six months, most often due to cost or insurance barriers.
​
Because obesity is a chronic condition, we designed a program that lowers costs over time—supporting long-term, physician-led care.
​
Based on real-world persistence studies of FDA-approved anti-obesity medications.
Local Physician-Led Care vs Online Telehealth Apps
Pricing structures and care models vary by provider. Many online telehealth weight-loss programs separate membership or subscription fees from medication costs, and pricing can rise with higher doses depending on the provider and plan structure.